David N Assis

6PUBLICATIONS
27CO-AUTHORS
Toxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)PainCardiology (incl. cardiovascular diseases)Discourse and pragmatics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 11, 2026
Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis.

Adrielly Martins, Anish Reddy, Richard Dean

|Feb 18, 2026
Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective Study.

Mariko Maxwell, Yanhong Deng, Bonnie Chen

|May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registry.

Richard Dean, Maryam Yazdanfar, Joseph Zepeda

|Aug 06, 2024
Pathophysiology of Cystic Fibrosis Liver Disease.

Vania L Kasper, David N Assis

|Feb 02, 2023
Reply: Living donor liver transplantation for people with PSC.

Lisa M Forman, Gonzalo Sapisochin, David N Assis

|Jan 25, 2023
Reply: Insurance should cover vancomycin for primary sclerosing cholangitis.

Christopher L Bowlus, Lionel Arrivé, Annika Bergquist

Pageof 1